Glen Swartz

Advanced Bioscience Laboratories, Inc.

$1,137,319

Attributed

$1,137,319

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $820.2K · FY2017–23

$1M$750K$500K$250K$0

'17

'18

'19

'20

'21

'22

'23

Funding mix

By agency

NIH$1,137,319 · 1

By mechanism

N01$1,137,319 · 1

Top collaborators

No co-investigators on record.

Most similar at Advanced Bioscience Laboratories, Inc.

Same institution · by research overlap

Timothy Fouts$52,990,932
Peter Silvera$18,392,128
Glenn Swartz$1,044,520
Ranajit Pal$45,474,422
Fred Mack$9,334,595

Others in their field

Other Emerging Leaders on “Prevention Strategy”

Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
Yunda Huang · Fred Hutchinson Cancer Center$54,053,670
Mark Marino · Venturewell$48,913,644
Olwen Hahn · Brigham And Women'S Hospital$31,632,321
Bryan Faller · Decatur Memorial Hospital$29,346,991

Research focus

Prevention StrategyLicensurePreventionPreventive VaccineSexual Hiv TransmissionMicrobicidePre-ClinicalPreventNational Institute Of Allergy And Infectious DiseaseResearch Clinical TestingAids PreventionPlayUnited States National Institutes Of HealthTechnologyHiv InfectionsClinical TrialsAcquired Immunodeficiency SyndromePre-Exposure ProphylaxisResourcesFutureServicesUnited States Food And Drug AdministrationAnti-Hiv MicrobicideHigh Risk